Elon Musk's brain-computer interface (BCI) company Neuralink has been given the green light to test its device in tetraplegic patients in Canada – the first international trial of the technology.
In 2023, Neuralink received FDA approval to start its first human trials for the N1 implant. Neuralink’s PRIME Study is actively enrolling people aged 22 and older with quadriplegia—limited ...
The U.S. Food and Drug Administration gave the green light in May 2023 for Neuralink to begin human clinical trials for its Telepathy brain chip. Last year, the company launched a similar brain ...
Brain computer interface (BCI) company Neuralink has been given regulatory approval to start a new trial of its implant to see if it can be used to control a robotic arm. If it proves to be ...
Elon Musk’s Neuralink has selected Miami as a clinical trial site for its brain-computer interface. Musk’s Neuralink makes devices that link the human brain to computers, focusing on giving ...
Elon Musk’s Neuralink suggests that a human patient might have successfully used the company’s brain chip to remotely control a robot. A short video clip posted Thursday shows a robot arm ...
In January 2024, Elon Musk's neurotechnology company, Neuralink, conducted their first human trial. The first-ever patient was a 29-year-old man named Noland Arbaugh, who had been paralyzed.
The clinical trial will assess the safety and functionality of Neuralink's N1 implant, a brain-computer interface that establishes a wireless, digital link between the brain and a computer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results